phototechno/iStock via Getty Images Earnings season heats up in mid-October, featuring results from a stellar lineup of companies across various sectors. This week's highlights include major players in finance, healthcare, technology and consumer goods, such as Bank of America (BAC), Johnson & Johnson (JNJ), Netflix (NFLX), Nokia (NOK), Taiwan Semiconductor (TSM) and Citigroup (C). Investors will also closely watch earnings from Procter & Gamble (PG), UnitedHealth (UNH), ASML Holding (ASML), Goldman Sachs (GS), Blackstone (BX), Walgreens Boots Alliance (WBA), Abbott Laboratories (ABT), Morgan Stanley (MS), American Express (AXP), Schlumberger (SLB), Intuitive Surgical (ISRG), Crown Castle (CCI), United Airlines (UAL), Alcoa (AA), U.S. Bancorp (USB) and Prologis (PLD). Below is a rundown of major quarterly updates anticipated in the week of October 14 to 18: Monday, October 14 The week will kick off with a light schedule of earnings reports, with Karooooo (KARO) set to release its earnings after the market closes. Tuesday, October 15 Bank of America Corporation (BAC) Bank of America (BAC) is set to release its Q3 earnings before the market opens on Tuesday, alongside Citigroup (C) and Goldman Sachs (GS). This comes shortly after JPMorgan (JPM), BlackRock (BLK) and Wells Fargo (WFC) posted their earnings results. Meanwhile, Warren Buffett's Berkshire Hathaway (BRK.A) further reduced its stake in BAC, selling over 9.5M shares from October 8 to 10, bringing its total holdings to 775M shares, or 9.99% of BAC's outstanding shares. With the stake below 10%, Berkshire is no longer required to report transactions within two business days, giving Buffett more flexibility in trading without public scrutiny. This move continues a selling trend that began in mid-July, with Berkshire cashing out over $10 billion from BAC. SA contributor Noah's Arc Capital Management remains optimistic on the stock, maintaining a Strong Buy rating, citing the bank's AI investments, such as Erica, and predicting potential earnings surprises driven by AI-driven cost savings and strong performance in investment banking. On the bearish side, SA contributor Paul Franke views Buffett’s recent sales as a signal of caution ahead of a potential bear market. Franke points out that BAC has underperformed the S&P 500 and the broader financial sector since 2007, and technical indicators suggest potential downside risk. Seeking Alpha's Quant Rating system assigns a Strong Buy rating to Bank of America (BAC), aligning with the bullish sentiment expressed by Wall Street analysts, who have issued a consensus Buy rating for the stock. Consensus EPS Estimates: $0.76 Consensus Revenue Estimates: $25.23B Earnings Insight: The bank has exceeded EPS expectations in 6 of the past 8 quarters, beating revenue estimates in 7 of those reports. Also reporting: Johnson & Johnson (JNJ), Citigroup (C), The Goldman Sachs Group (GS), Walgreens Boots Alliance (WBA), UnitedHealth Group (UNH), United Airlines Holdings (UAL), Telefonaktiebolaget LM Ericsson (publ) (ERIC), The Charles Schwab Corporation (SCHW), The PNC Financial Services Group (PNC), Omnicom Group (OMC), State Street (STT), The Progressive Corporation (PGR), Interactive Brokers Group (IBKR), J.B. Hunt Transport Services (JBHT) and more. Wednesday, October 16 Abbott Laboratories (ABT) Healthcare giant Abbott Laboratories (ABT) is scheduled to report its Q3 earnings on Wednesday, with analysts expecting approximately 5% growth in earnings and a 4% increase in revenue. The company recently secured FDA approval for a device treating tricuspid regurgitation and clearance for its i-STAT TBI test cartridge, which delivers lab-quality results for concussion diagnosis within 15 minutes. Analyst sentiment is generally positive. Oppenheimer recently initiated coverage of Abbott with an Outperform rating, highlighting its diverse product portfolio and favorable risk-reward profile. Similarly, Piper Sandler rated the stock as Outperform, citing the current valuation as an attractive buying opportunity, despite underperformance earlier this year. However, Seeking Alpha's Quant Rating System assigns a Hold rating to ABT, contrasting with the consensus Buy rating from Wall Street analysts. SA Investing Group leader Leo Nelissen believes Abbott's diversified growth, driven by innovative medical devices and established pharmaceuticals, positions it for long-term success and market outperformance. Despite legal challenges and post-pandemic headwinds, Abbott's robust earnings growth and solid dividend profile make it an attractive investment, the analyst said. Consensus EPS Estimates: $1.20 Consensus Revenue Estimates: $10.55B Earnings Insight: The company has exceeded EPS and revenue expectations in a straight 8 quarters. Also reporting: Kinder Morgan (KMI), Morgan Stanley (MS), ASML Holding N.V. (ASML), Alcoa Corporation (AA), Crown Castle (CCI), U.S. Bancorp (USB), CSX Corporation (CSX), Prologis (PLD), Discover Financial Services (DFS), Synchrony Financial (SYF), PPG Industries (PPG), Steel Dynamics (STLD), Citizens Financial Group (CFG) and more. Thursday, October 17 Netflix (NFLX) Streaming giant Netflix (NFLX) is scheduled to report its Q3 financial results on Thursday, after the closing bell. The analysts expect bottom-line growth of 37% Y/Y on top-line growth of 14%. The stock has surged over 96% in the past 12 months and is up nearly 50% YTD, earning a Buy recommendation from Wall Street analysts, who are mostly bullish on Netflix (NFLX) ahead of its third-quarter earnings report. Oppenheimer believes NFLX's initiatives, such as password sharing rules, advertising and pricing increases, will drive subscriber growth and revenue. Morgan Stanley sees a long runway for revenue growth and a deepening competitive market. Citi Research, however, maintains a Neutral rating, citing potential challenges in achieving $25 EPS in 2025. Despite differing views, analysts agree that NFLX's dominance in the streaming market will continue. Meanwhile, the Seeking Alpha Quant Rating system maintains a Hold rating on the stock. SA contributor Pearl Gray Equity and Research highlighted Netflix’s (NFLX) robust growth in the LATAM region, while its UCAN segment continues to serve as a solid foundation for advertising revenue. Although growth in the APAC region has slowed in recent quarters due to rising competition, they see potential for a turnaround driven by China's stimulus package. Pearl Gray also noted that despite these challenges, Netflix remains an undervalued asset with attractive shareholder return metrics. Consensus EPS Estimates: $5.11 Consensus Revenue Estimates: $9.76B Earnings Insight: Netflix has risen above EPS estimates in 6 of the past 8 quarters while exceeding revenue expectations in 5 of those reports. Also reporting: Nokia Oyj (NOK), Taiwan Semiconductor Manufacturing Company Limited (TSM), Blackstone (BX), Intuitive Surgical (ISRG), Rio Tinto Group (RIO), Truist Financial Corporation (TFC), M&T Bank Corporation (MTB), The Travelers Companies (TRV), Huntington Bancshares Incorporated (HBAN), KeyCorp (KEY), Infosys Limited (INFY), Iridium Communications (IRDM) and more. Friday, October 18 Schlumberger (SLB) Schlumberger (SLB), the world’s largest oilfield service company, is slated to report Q3 results before the market opens on Friday, with analysts anticipating more than 12% Y/Y growth in both EPS and revenue. Wall Street analysts have given the stock a Strong Buy rating, while Seeking Alpha's Quant Rating system remains more cautious, maintaining a Hold rating. SA author Research Wise believes Schlumberger's international division, particularly in the Middle East and Asia, is driving robust growth despite a decline in North America due to weak prices and lower drilling activities. Tailwinds from offshore projects, geographic expansion, and operational improvements are expected to fuel long-term revenue growth and margin improvement. Research Wise considers SLB to be an attractive buy at its current discounted valuation, given its promising long-term outlook. Consensus EPS Estimates: $0.89 Consensus Revenue Estimates: $9.32B Earnings Insight: The company has beaten EPS estimates in 8 straight quarters and revenue estimates in 6 of those reports. Also reporting: The Procter & Gamble Company (PG), American Express Company (AXP), Regions Financial Corporation (RF), Ally Financial (ALLY), Fifth Third Bancorp (FITB), SCYNEXIS (SCYX), Robert Half (RHI), Watsco (WSO) and more.